Back
Black Diamond Therapeutics, Inc. 10K Form
Sell
2
BDTX
Black Diamond Therapeutics, Inc.
Last Price:
$2.70
Seasonality Move:
-28.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BDTX News And Ratings
See the #1 stock for the next 7 days that we like better than BDTX
BDTX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-7.9M |
| Price / Cash Flow: | 7.24 |
| Annual Sales: | $2.22 |
| Price / Book: | 1.22 |
Profitability
| EPS (TTM): | 0.36280 |
|---|---|
| Net Income (TTM): | $21.5M |
| Gross Margin: | $-343K |
| Return on Equity: | 18.5% |
| Return on Assets: | 14.13% |
Black Diamond Therapeutics, Inc. Earnings Forecast
Key Black Diamond Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 8 years have been positive in 3 years.
Black Diamond Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BDTX |
| CUSIP: | 09203E |
| Website: | blackdiamondtherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0.16 |
|---|---|
| Current Ratio: | 8.94 |
| Quick Ratio: | 8.72 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BDTX Technical Analysis vs Fundamental Analysis
Sell
2
Black Diamond Therapeutics, Inc. (BDTX)
is a Sell
Is Black Diamond Therapeutics, Inc. a Buy or a Sell?
-
Black Diamond Therapeutics, Inc. stock is rated a SellThe current Black Diamond Therapeutics, Inc. [BDTX] share price is $2.71. The Score for BDTX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.